On Invalid Date, Zynerba Pharmaceuticals (NASDAQ: ZYNE) reported Q3 2022 earnings per share (EPS) of -$0.20, up 23.08% year over year. Total Zynerba Pharmaceuticals earnings for the quarter were -$8.68 million. In the same quarter last year, Zynerba Pharmaceuticals's earnings per share (EPS) was -$0.26.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.